Have a feature idea you'd love to see implemented?
Let us know!
INSP Inspire Medical Systems Inc
Price (delayed)
$186.29
Market cap
$5.58B
P/E Ratio
166.33
Dividend/share
N/A
EPS
$1.12
Enterprise value
$5.46B
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the
Highlights
The gross profit has grown by 34% YoY and by 7% from the previous quarter
Inspire Medical Systems's revenue has increased by 33% YoY and by 7% from the previous quarter
The company's quick ratio fell by 15% QoQ and by 12% YoY
INSP's debt is up by 2.9% QoQ
Key stats
What are the main financial stats of INSP
Market
Valuations
Earnings
Shares outstanding
29.97M
Market cap
$5.58B
Enterprise value
$5.46B
Price to earnings (P/E)
166.33
Price to book (P/B)
7.98
Price to sales (P/S)
7.37
EV/EBIT
147.35
EV/EBITDA
128.9
EV/Sales
7.23
Revenue
$755.59M
Gross profit
$640.54M
Net income
$33.05M
EBIT
$37.06M
EBITDA
$42.36M
Free cash flow
$38.2M
Per share
Balance sheet
Liquidity
EPS
$1.12
EPS diluted
$1.09
Free cash flow per share
$1.28
Book value per share
$23.36
Revenue per share
$25.29
TBVPS
$26.65
Total assets
$796.19M
Total liabilities
$99.63M
Debt
$25.22M
Equity
$696.56M
Working capital
$508.26M
Debt to equity
0.04
Current ratio
7.84
Quick ratio
6.74
Net debt/EBITDA
-2.89
Margins
Efficiency
Dividend
EBITDA margin
5.6%
Gross margin
84.8%
Net margin
4.4%
Operating margin
1.8%
Return on assets
4.6%
Return on equity
5.3%
Return on invested capital
7.4%
Return on capital employed
5.1%
Return on sales
4.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INSP stock price
How has the Inspire Medical Systems stock price performed over time
Intraday
-0.69%
1 week
-2.32%
1 month
-1.29%
1 year
-4.67%
YTD
-8.43%
QTD
-11.73%
Financial performance
How have Inspire Medical Systems's revenue and profit performed over time
Revenue
$755.59M
Gross profit
$640.54M
Operating income
$13.5M
Net income
$33.05M
Gross margin
84.8%
Net margin
4.4%
The operating income has soared by 194% since the previous quarter and by 127% year-on-year
The operating margin has soared by 190% from the previous quarter and by 120% YoY
INSP's net margin has soared by 177% YoY
The gross profit has grown by 34% YoY and by 7% from the previous quarter
Growth
What is Inspire Medical Systems's growth rate over time
Valuation
What is Inspire Medical Systems stock price valuation
P/E
166.33
P/B
7.98
P/S
7.37
EV/EBIT
147.35
EV/EBITDA
128.9
EV/Sales
7.23
The P/B is 52% below the 5-year quarterly average of 16.7 and 12% below the last 4 quarters average of 9.1
The company's equity rose by 28% YoY and by 9% QoQ
The stock's P/S is 65% less than its 5-year quarterly average of 21.3 and 11% less than its last 4 quarters average of 8.3
Inspire Medical Systems's revenue has increased by 33% YoY and by 7% from the previous quarter
Efficiency
How efficient is Inspire Medical Systems business performance
INSP's return on sales has surged by 188% year-on-year
INSP's ROE has soared by 184% year-on-year
INSP's ROA has soared by 184% YoY
INSP's ROIC has soared by 130% YoY
Dividends
What is INSP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INSP.
Financial health
How did Inspire Medical Systems financials performed over time
The company's total assets rose by 25% YoY and by 9% QoQ
The current ratio has declined by 15% since the previous quarter and by 3.7% year-on-year
INSP's debt is 96% lower than its equity
The company's equity rose by 28% YoY and by 9% QoQ
INSP's debt to equity is down by 20% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.